Novartis Investigative Site

Waterville, Maine 04901

0 studies enrolling now · 2 studies all time

What they study most

Neoplasms, Breast, Non-Hodgkin's Lymphoma

Studies at this site

• Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy — Stopped early
• EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING